The Indian government has proposed to fully exempt three cancer medicines from custom duties, aiming to make advanced cancer treatments more affordable and accessible. The move also includes reductions in duties on medical technologies like x-ray tubes and flat panel detectors, supporting domestic healthcare capabilities.